GC-MS profiling, anticancer activity of Moringa oleifera Lam. hydroalcoholic fruit extract against colorectal cancer cells, and In Silico targeting of BRAF in the serrated pathway
Key Points
Moringa oleifera extract demonstrated significant anticancer activity against colorectal cancer cells, indicating its potential for treatment.
In silico targeting revealed promising interactions with BRAF within the serrated pathway, providing insights into molecular mechanisms.
Assessment using GC-MS profiling highlighted the composition of the hydroalcoholic extract, correlating specific compounds with anticancer effects.
Further exploration on human models needed to validate the observed effects of the Moringa oleifera extract on cancer cells.
GC-MS profiling, anticancer activity of Moringa oleifera Lam. hydroalcoholic fruit extract against colorectal cancer cells, and In Silico targeting of BRAF in the serrated pathway | Synapse